Get the Stockscreener App
3.295
0.18%
-0.049
Bluejay Diagnostics Inc stock is traded at $3.295, with a volume of 60,838.
It is down -0.18% in the last 24 hours and up +19.29% over the past month.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.
See More
Previous Close:
$3.246
Open:
$3.49
24h Volume:
60,838
Relative Volume:
1.97
Market Cap:
$1.49M
Revenue:
-
Net Income/Loss:
$-8.59M
P/E Ratio:
-0.0024
EPS:
-1373
Net Cash Flow:
$-9.25M
1W Performance:
-7.32%
1M Performance:
+19.29%
6M Performance:
-48.73%
1Y Performance:
-80.30%
1-Day Range:
$3.20
$3.68
1-Week Range:
$2.84
$4.00
52-Week Range:
$2.5092
$40.80
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics Inc
Sector
Industry
Phone
(978) 631-0152
Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
3.295 | 368.04K | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
106.22 | 184.41B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
92.77 | 139.09B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.77 | 136.84B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.66 | 129.21B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
81.04 | 47.50B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bluejay Diagnostics Inc Stock (BJDX) Latest News
Bluejay Diagnostics announces 1-for-4 reverse stock split By Investing.com - Investing.com Australia
Bluejay Diagnostics announces reverse stock split - Medical Buyer
Bluejay Diagnostics announces 1-for-4 reverse stock split - Investing.com
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - marketscreener.com
Bluejay Diagnostics cuts share count to ~708K in 1-for-4 reverse split - Stock Titan
Valuation Update: Is Bluejay Diagnostics Inc stock a smart retirement pick2025 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Investment Report: How is Bluejay Diagnostics Inc managing supply chain issuesJuly 2025 Gainers & Community Verified Trade Signals - baoquankhu1.vn
Published on: 2026-01-14 07:07:38 - Bộ Nội Vụ
Buybacks Report: Is Bluejay Diagnostics Inc forming a breakout patternTrade Ideas & Community Shared Stock Ideas - baoquankhu1.vn
How Bluejay Diagnostics Inc. stock trades before earnings2025 Major Catalysts & Proven Capital Preservation Methods - ulpravda.ru
Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Bluejay Diagnostics Raises $3.7M Through Warrant Deal, Stock Slides After-Hours While Retail Interest Surges - MSN
Why Bluejay Diagnostics Inc. stock remains a top recommendationJuly 2025 Setups & Technical Pattern Alert System - Улправда
How supply chain issues affect Bluejay Diagnostics Inc. stockSell Signal & Entry Point Confirmation Alerts - ulpravda.ru
Is Bluejay Diagnostics Inc. stock attractive for passive investorsQuarterly Profit Review & Daily Chart Pattern Signals - Улправда
Is Bluejay Diagnostics Inc. stock a safe haven assetJuly 2025 Action & AI Optimized Trade Strategies - Улправда
Can Bluejay Diagnostics Inc. stock beat market expectations this quarter - Улправда
Is Bluejay Diagnostics Inc. stock a defensive play in 2025MACD Histogram Signals & Subscribe for Free Weekly Winners - ulpravda.ru
2026 world cup star players tips: Why Bluejay Diagnostics Inc. stock could see breakout soon2026 world cup usa national team group stage goalkeepers transition play knockout prediction insights - ulpravda.ru
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
What analysts say about Bluejay Diagnostics Inc stockPortfolio Diversification Tips & Outstanding Growth Stocks - earlytimes.in
Why Bluejay Diagnostics Inc. stock could see breakout soonRSI Overbought/Oversold & Big Profit Small Budget - bollywoodhelpline.com
Bluejay Diagnostics Completes Commercial-Scale IL-6 Antibody Production - TradingView — Track All Markets
Working capital per share of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView — Track All Markets
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Significant Increase in Short Interest - Defense World
Bluejay Diagnostics completes antibody production for IL-6 test system By Investing.com - Investing.com Nigeria
Bluejay Diagnostics announces completion of commercial-scale IL-6 antibody production - marketscreener.com
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production - TradingView — Track All Markets
Bluejay Diagnostics completes antibody production for IL-6 test system - Investing.com
Bluejay Diagnostics, Inc. Completes Commercial-Scale Production of IL-6 Antibodies for Symphony™ System - Quiver Quantitative
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Enough IL-6 test antibodies made to power 9M diagnostic cartridges - Stock Titan
Bluejay Diagnostics Stock Plummets 37% With 11-Day Losing Streak - Trefis
10-Day Sell-Off Sends Bluejay Diagnostics Stock Down 34% - Trefis
Can Bluejay Diagnostics Inc. stock hit record highs againWeekly Market Report & Entry Point Strategy Guides - Улправда
What makes Bluejay Diagnostics Inc. stock attractive to growth fundsWeekly Market Outlook & Free Safe Capital Growth Stock Tips - DonanımHaber
Bluejay Diagnostics Earnings Notes - Trefis
This trade activity should not be overlooked: Bluejay Diagnostics Inc (BJDX) - Setenews
Can Bluejay Diagnostics Inc. stock sustain institutional interestJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Bluejay Diagnostics (BJDX) Stock Analysis Report | Financials & Insights - Benzinga
Bluejay Diagnostics (NASDAQ:BJDX) Shares Down 6.2% – Time to Sell? - Defense World
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):